Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Conmed Raises FY2025 Adj EPS Guidance from $4.25-$4.40 to $4.45-$4.60 vs $4.34 Est; Raises FY2025 Sales Guidance from $1.34B-$1.37B to $1.35B-$1.38B vs $1.36B Est

Author: Benzinga Newsdesk | April 30, 2025 03:23pm
Conmed (NYSE:CNMD) raises FY2025 Adj EPS guidance from $4.25-$4.40 to $4.45-$4.60 vs $4.34 analyst estimate. Raises FY2025 sales outlook from $1.34 billion-$1.37 billion to $1.35 billion-$1.38 billion vs $1.36 billion estimate.

Posted In: CNMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist